Mirum Pharmaceuticals, Inc. Foreign Currency Transaction Gain Loss Unrealized After Tax
Mirum Pharmaceuticals, Inc. (MIRM) reported Foreign Currency Transaction Gain Loss Unrealized After Tax of $600.00 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-04.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossUnrealizedAfterTax · last filed 2025-11-04
- Mirum Pharmaceuticals, Inc. foreign currency transaction gain loss unrealized after tax for the quarter ending 2025-09-30 was $600.00K.
- Mirum Pharmaceuticals, Inc. foreign currency transaction gain loss unrealized after tax for the quarter ending 2025-06-30 was $600.00K, a 50.00% increase year-over-year.
- Mirum Pharmaceuticals, Inc. foreign currency transaction gain loss unrealized after tax for the quarter ending 2024-09-30 was -$1.00M.
- Mirum Pharmaceuticals, Inc. foreign currency transaction gain loss unrealized after tax for the quarter ending 2024-06-30 was $400.00K.
| Period end | Foreign Currency Transaction Gain Loss Unrealized After Tax 3 month | Foreign Currency Transaction Gain Loss Unrealized After Tax 6 month | Foreign Currency Transaction Gain Loss Unrealized After Tax 9 month |
|---|---|---|---|
| 2025-09-30 | $600.00K 10-Q · filed 2025-11-04 | $1.20M derived: sum of 2 quarters · filed 2025-11-04 | $1.90M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $600.00K 10-Q · filed 2025-08-06 | $1.30M 10-Q · filed 2025-08-06 | |
| 2024-09-30 | -$1.00M 10-Q · filed 2025-11-04 | -$600.00K derived: sum of 2 quarters · filed 2025-11-04 | $1.10M 10-Q · filed 2025-11-04 |
| 2024-06-30 | $400.00K 10-Q · filed 2025-08-06 | $2.10M 10-Q · filed 2025-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |